Molecular Mechanisms of Intestinal Metal Ion Transport During Iron-Deficiency

缺铁期间肠道金属离子转运的分子机制

基本信息

  • 批准号:
    7706543
  • 负责人:
  • 金额:
    $ 26.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall control of iron homeostasis occurs at the transport step in the epithelium of the proximal small bowel, where absorption is precisely regulated to match body iron losses. Importantly, perturbations in intestinal iron transport are associated with several important disease states in humans, including anemia of chronic disease and hemochromatosis. Intestinal copper transport is enhanced in rats during iron-deficiency, and this is likely a physiological response related to the role of dietary copper in various aspects of overall body iron homeostasis. Interestingly, the Menkes copper ATPase (Atpya) is strongly induced in the duodenal mucosa of iron-deprived rats at different postnatal ages along with Divalent Metal Transporter i (Dmti), which can transport iron and copper. Thus, the overall goals of this proposal are i) to determine the roles that Dmti and Atpya play in the induction of copper transport during iron-deprivation, 2) to decipher the molecular mechanisms of induction of Dmti and Atpya during iron-deprivation and 3) to determine the effect that copper has on molecular mechanisms of trans-epithelial iron transport in the intestine. This will be accomplished by utilizing cell culture and rodent models of intestinal iron transport. Specific AIM i will test the hypothesis that induction of Dmti and Atpya is responsible for increased transepithelial copper transport seen during iron-deprivation. Iron and copper transport studies and siRNA knockdowns will be performed in our in vitro model of the intestinal epithelium, the IEC-6 cells. Once the transporter(s) involved in the induction of copper transport during iron-deficiency have been identified, we will perform complementary studies in in vivo models of iron-deficiency, including wild-type, iron-deficient rats, Belgrade (i.e. Dmti-deficient) rats and Atpya knockout mice. Specific AIM 2, will test the hypothesis that Dmti and Atpya are regulated by distinct molecular mechanisms during iron-deficiency. Iron-dependent, post- transcriptional regulation of Dmti will be examined (mediated by the 3' IRE) and transcriptional regulation of Atpya in IEC-6 cells will be studied. Finally, specific AIM 3 will test the hypothesis that increased copper transport during iron deficiency functions to enhance copper-dependent aspects of intestinal iron absorption. To accomplish this goal, iron transport studies will be performed in membrane vesicles isolated from iron-deficient rats deprived of dietary copper, and hephaestin activity in enterocytes and ceruloplasmin activity in serum will be determined. Overall, these studies will allow further definition of the copper- dependent processes that are involved in enhancing intestinal iron absorption during states of iron- deficiency. A detailed understanding of these relationships is critical, as intestinal iron transport controls overall body iron homeostasis. Moreover, this proposed investigation is novel, as studies addressing the impact of increased enterocyte and liver copper levels during iron-deficiency have not been reported to date.
描述(由申请人提供):铁的动态平衡的总体控制发生在近端小肠上皮的运输步骤,在那里吸收被精确地调节以匹配身体铁损失。重要的是,肠道铁转运的紊乱与人类的几种重要疾病状态有关,包括慢性病贫血和血色素沉着症。缺铁时大鼠肠道铜转运增强,这可能是一种生理反应,与膳食铜在体内铁平衡的各个方面所起的作用有关。有趣的是,门克斯铜ATPase(Atpya)与二价金属转运蛋白I(DMTI)一起,在出生后不同年龄缺铁大鼠的十二指肠粘膜中被强烈诱导,DMTI可以运输铁和铜。因此,这项建议的总体目标是:1)确定DMTI和ATPTA在缺铁诱导铜运输中的作用;2)破译缺铁诱导DMTI和ATPTA的分子机制;3)确定铜对肠道跨上皮铁运输的分子机制的影响。这将通过利用细胞培养和啮齿动物模型的肠道铁运输来实现。具体目的I将验证DMTI和ATPTA的诱导是缺铁时跨上皮铜转运增加的原因的假设。铁和铜的运输研究和siRNA敲除将在我们的肠上皮细胞IEC-6细胞的体外模型中进行。一旦确定了在缺铁期间诱导铜运输的转运体(S),我们将在体内缺铁模型中进行补充研究,包括野生型缺铁大鼠、贝尔格莱德(即DMTI缺乏)大鼠和Atpya基因敲除小鼠。特异性AIM 2,将检验DMTI和ATPTA在缺铁期间受不同分子机制调控的假说。将研究DMTI铁依赖的转录后调控(由3‘IRE介导),并研究ATPTA在IEC-6细胞中的转录调控。最后,特定的AIM 3将检验这一假说,即在缺铁期间增加铜的运输功能,以增强肠道铁吸收的铜依赖方面。为了实现这一目标,将对缺铁缺铜大鼠分离的膜微囊中铁的转运进行研究,并测定肠细胞中的Hephestn活性和血清中的铜蓝蛋白活性。总体而言,这些研究将进一步定义在缺铁状态下促进肠道铁吸收的铜依赖过程。对这些关系的详细了解是至关重要的,因为肠道铁运输控制着全身铁的动态平衡。此外,这项拟议的研究是新颖的,因为到目前为止还没有关于缺铁期间肠细胞和肝脏铜水平增加的影响的研究报告。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James F. Collins其他文献

<span class="small-caps">dl</span>-2-[3,4-<sup>3</sup>H]Amino-4-phosphonobutyrate binding sites in the rat hippocampus: distribution and possible physiological role
  • DOI:
    10.1016/0006-8993(87)90596-8
  • 发表时间:
    1987-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Steven P. Butcher;Peter J. Roberts;James F. Collins
  • 通讯作者:
    James F. Collins
Independence of sensitivity on different foveal areas
ACELL November 46/5
ACELL 十一月 46/5
  • DOI:
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Y. Guner;P. Kiela;XU Hua;James F. Collins;F. Ghishan
  • 通讯作者:
    F. Ghishan
Aminoacyltransferase II from Rat Liver: I. PURIFICATION AND ENZYMATIC PROPERTIES
  • DOI:
    10.1016/s0021-9258(18)62428-7
  • 发表时间:
    1971-02-25
  • 期刊:
  • 影响因子:
  • 作者:
    Samuel Raeburn;James F. Collins;Hong Mo Moon;Elizabeth S. Maxwell
  • 通讯作者:
    Elizabeth S. Maxwell
Molecular cloning, promoter characterization, and gene structure of murine intestinal type IIB sodium-phosphate cotransporter gene
  • DOI:
    10.1016/s0016-5085(00)80270-x
  • 发表时间:
    2000-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Kayo Arima;James F. Collins;Eric R. Hines;Liqun Bai;Fayez K. Ghishan
  • 通讯作者:
    Fayez K. Ghishan

James F. Collins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James F. Collins', 18)}}的其他基金

Iron Pathobiology in β-thalassemia Pregnancy
妊娠β地中海贫血中的铁病理学
  • 批准号:
    10923418
  • 财政年份:
    2023
  • 资助金额:
    $ 26.85万
  • 项目类别:
Mechanisms of Heme and Non-heme Iron Absorption in Murine Models of Iron Overload
铁过载小鼠模型中血红素和非血红素铁吸收的机制
  • 批准号:
    10701227
  • 财政年份:
    2022
  • 资助金额:
    $ 26.85万
  • 项目类别:
Divalent Metal-ion Transporter 1 as a Therapeutic Target to Optimize Intestinal Iron Transport
二价金属离子转运蛋白 1 作为优化肠道铁转运的治疗靶点
  • 批准号:
    9920132
  • 财政年份:
    2016
  • 资助金额:
    $ 26.85万
  • 项目类别:
Divalent Metal-ion Transporter 1 as a Therapeutic Target to Optimize Intestinal Iron Transport
二价金属离子转运蛋白 1 作为优化肠道铁转运的治疗靶点
  • 批准号:
    9314563
  • 财政年份:
    2016
  • 资助金额:
    $ 26.85万
  • 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron Deficiency
缺铁期间肠道金属离子转运的分子机制
  • 批准号:
    8506803
  • 财政年份:
    2007
  • 资助金额:
    $ 26.85万
  • 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron Deficiency
缺铁期间肠道金属离子转运的分子机制
  • 批准号:
    9919534
  • 财政年份:
    2007
  • 资助金额:
    $ 26.85万
  • 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron Deficiency
缺铁期间肠道金属离子转运的分子机制
  • 批准号:
    8813554
  • 财政年份:
    2007
  • 资助金额:
    $ 26.85万
  • 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron-Deficiency
缺铁期间肠道金属离子转运的分子机制
  • 批准号:
    7636746
  • 财政年份:
    2007
  • 资助金额:
    $ 26.85万
  • 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron-Deficiency
缺铁期间肠道金属离子转运的分子机制
  • 批准号:
    7587761
  • 财政年份:
    2007
  • 资助金额:
    $ 26.85万
  • 项目类别:
Molecular Mechanisms of Intestinal Metal Ion Transport During Iron-Deficiency
缺铁期间肠道金属离子转运的分子机制
  • 批准号:
    8098833
  • 财政年份:
    2007
  • 资助金额:
    $ 26.85万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 26.85万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 26.85万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.85万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.85万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 26.85万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.85万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 26.85万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 26.85万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 26.85万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.85万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了